Boris Y. Zaslavsky is Chief Scientific Officer at Cleveland Diagnostics, Inc., which he co-founded in 2013. He trained as a bioanalytical chemist at Moscow State University before joining the USSR Academy of Sciences. He moved to the United States in 1991 to take up a visiting scholar position at Cornell Medical College in New York City, and later worked at KV Pharmaceuticals and Argonne National Laboratory. In 1996, he co-founded Analiza, Inc. Dr. Zaslavsky developed analytical applications of extraction in aqueous two-phase systems and pioneered Solvent Interaction Analysis, used for quality control of biopharmaceuticals and for clinical testing aimed at early cancer detection. He has authored numerous research papers and reviews, as well as one previous book.Prof. Vladimir N. Uversky, PhD, DSc, FRSB, FRSC, F.A.I.M.B.E., Professor at the Department of Molecular Medicine, Morsani College of Medicine, University of South Florida (USF), is a pioneer in the field of protein intrinsic disorder. He has made a number of groundbreaking contributions in the field of protein folding, misfolding, and intrinsic disorder. He obtained his PhD from Moscow Institute of Physics and Technology and D.Sc. from the Institute of Experimental and Theoretical Biophysics, Russian Academy of Sciences. Since 2010, Professor Uversky has worked at University of South Florida, where he works on various aspects of protein intrinsic disorder phenomenon and analysis of protein folding and misfolding processes. He has authored over 1250 scientific publications and edited several books and book series on protein structure, function, folding, misfolding, and intrinsic disorder. He also servs as an editor in a number of scientific journals.